Strategic Overview
OliLux develops DMN-Tre, a decentralized molecular test for TB diagnosis.
Innovation Portfolio
DMN-Tre
Innovative diagnostic solution.
Decent. Mol.
Sputum
Key Milestones
DMN-Tre decentralized molecular test
District-level capability
Sputum-based testing
Early-stage clinical development